Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-28

Clinical Trial Update: The Effect of High-dose Silybin-phytosome in Men With Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of high-dose silybin-phytosome in men with prostate cancer has completed. Results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Silybin-phytosome (silybin-phytosome)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-02-28